The Swiss franc could extend its recent decline if optimism over a Ukraine-Russia ceasefire deal reduces safe-haven demand and data Thursday show Swiss inflation eased in January, ING said.

Explore why the USD/CHF pair may continue to rise, and what to expect in the coming months amid the Fed and SNB divergence ...

In a world where concrete is as ubiquitous as air, its environmental toll is impossible to ignore. The production of cement, ...

First Trust Switzerland AlphaDEX Fund is a lesser-known ETF that focuses on Swiss equities. Check out the factors that ...

The Swiss franc could appreciate in coming months as the Swiss National Bank is unlikely to return to negative interest rates, Commerzbank analyst Michael Pfister says in a note.

KfW became the 14th SSA issuer to visit the Swiss franc bond market this year on Thursday, ending a 15 year absence from the currency. While the German agency is no stranger to funding outside its ...

YinYang/istockphotoWhen it comes to money, we tend to think that the U.S. dollar reigns supreme. But there are a handful of ...

Find insight on ETFs, Julius Baer, the Malaysian banking sector and more in the latest Market Talks covering Financial ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

If you buy something, we may earn an affiliate commission. Swiss watch brands reflect its people. In a country where train schedules are timed to the second, and tidiness is happiness, there is ...

ZURICH, Jan 29 (Reuters) - Swiss biopharma company BioVersys said on Wednesday it had launched an initial public offering on the SIX stock exchange priced at 36 Swiss francs ($39.84) per share.

The Japanese yen is gaining 0.8%, pushing the USD/JPY cross back below the 155 mark, while the Swiss franc is 0.5% stronger with USD/CHF at 0.9018. The U.S. dollar can often be an FX haven too ...